What is MRNA's five-year median P/E?

The median, or middle weekly reading, is 7.0× over the last five years. Available history contains 285 weekly observations from May 10, 2021 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.

Moderna (MRNA) valuation history

As of Oct 22, 2026

MRNA's P/E is not meaningful because trailing earnings are negative.

A positive earnings base is needed to compare P/E readings. Find stocks with valuation history

Share P/E history

Shared chart range

Preview embed

Chart by stockresearch.app. Reuse with credit under CC BY 4.0.

P/E at year-end

Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.

MRNA year-end valuation history
Reading date	P/E	5-year rank
Dec 29, 2025	Unavailable	Short history
Dec 30, 2024	Unavailable	Short history
Dec 25, 2023	Unavailable	Short history
Dec 26, 2022	6.5×	46%
Dec 27, 2021	15.6×	7%

Peers on the same measure

Stock	P/E	5-year rank
ABBVAbbVie	80.5×	76%
AMGNAmgen	27.2×	78%
GILDGilead Sciences	Unavailable	Unranked
INCYIncyte	16.0×	9%

Appears in

Health Care Stocks with Low P/E Ratios and Steady Revenue Growth Stocks Below Their 5-Year Median P/E Stocks Near Their Lowest P/E Ratios in 5 Years

Research on MRNA

No published research on MRNA yet. Read how valuation percentiles work.

Loading related research…

About this history

What is MRNA's current P/E?: MRNA's P/E is not meaningful because trailing earnings are negative.
What is MRNA's five-year median P/E?: The median, or middle weekly reading, is 7.0× over the last five years. Available history contains 285 weekly observations from May 10, 2021 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.